Food companies fatten us up only for Big Pharma to let us inject ourselves slim again. Crazy? Perhaps it’s the beginning of the end for a destructive business model.
Ingo Arzt has a degree in electrical engineering and attended the German School of Journalism. He then worked for several years in the business and environment department of the “taz”, reporting on the climate crisis and, most recently, on vaccines and corona. Since June 2021 he has been an editor in the health department at ZEIT ONLINE.
Food companies fatten us up only for Big Pharma to let us inject ourselves slim again. Crazy? Perhaps it’s the beginning of the end for a destructive business model.
Beata Halassy’s aggressive form of breast cancer kept returning, until she chose to conduct a self-experiment. A molecular biologist, Halassy explored an untested treatment and injected herself with viruses to successfully fight off her cancer. It raises ethical debates, but also provides a glimpse into the future of personalized medicine.
Lecanemab, marketed as Leqembi, is the first drug targeting the root cause of Alzheimer’s disease to be approved by the European Medicines Agency. Despite its side effects and limited efficacy, it finally offers a glimmer of hope for effective therapies.